sitagliptin/mylan 25mg film coated tablets
mylan ireland limited (0000011082) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - sitagliptin hydrochloride monohydrate - film coated tablets - 25mg - sitagliptin hydrochloride monohydrate (8000004805) 28,344mg
apixaban/mylan 5mg film coated tablets
mylan ireland limited (0000011082) unit 35/36, grange parade, baldoyle industrial estate, dublin 13 - apixaban - film coated tablets - 5mg - apixaban (0503612473) 5mg
irbesartan/mylan 300mg/tab δισκιο
mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - irbesartan - ΔΙΣΚΙΟ - 300mg/tab - 0138402116 irbesartan 300.000000 mg - irbesartan
irbesartan/mylan 75mg/tab δισκιο
mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - irbesartan - ΔΙΣΚΙΟ - 75mg/tab - 0138402116 irbesartan 75.000000 mg - irbesartan
irbesartan/mylan 150mg/tab δισκιο
mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - irbesartan - ΔΙΣΚΙΟ - 150mg/tab - 0138402116 irbesartan 150.000000 mg - irbesartan
degarelix accord
accord healthcare s.l.u. - degarelix acetate - Νεοπλάσματα του προστάτη - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.